RE:RE:RE:RE:RE:BEST NOT ANY OF YOU TRY TO SPIN THESE FINANCIALS POSITIVEGood to hear from you Benedictus & always appreciate your insight as well...your points are well taken re: LDS & the CEO track record. As for SNN, despite the delays & cost overruns, their management team is a good one & SNN’s planned scale is unmatched. I will be waiting patiently on the sidelines until I get a better idea on their operational timelines & more clarity re: this recent legal action.
p.s. You are right about TLT!...hope to be accumulating more as well before preliminary results. Certainly has the potential to be the blockbuster of all junior biotechs/small caps...exciting times ahead. Best of luck...